Skip to content

Clinical Efficacy and Medication Characteristics of Heng-Gu-Gu-Shang-Yu-He-Ji in Fracture Treatment: A Real-World Study

Clinical Efficacy and Medication Characteristics of Heng-Gu-Gu-Shang-Yu-He-Ji in Fracture Treatment: A Real-World Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089624
Enrollment
Unknown
Registered
2024-09-12
Start date
2023-09-20
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture

Interventions

Exposure group:None
Non-exposed group:None

Sponsors

Beijing University Of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Meet the Western medical diagnostic criteria for fractures. 2.Test group: minimum consumption of 150ml of OsteoKing; Control group: no consumption of Henggu Bone Injury Healing Agent. 3. At least one follow-up imaging review post-treatment. 4. Age between 15 and 85 years.

Exclusion criteria

Exclusion criteria: 1. Meet the Western medical diagnostic criteria for fractures. 2.Test group: minimum consumption of 150ml of OsteoKing; Control group: no consumption of Henggu Bone Injury Healing Agent. 3. At least one follow-up imaging review post-treatment. 4. Age between 15 and 85 years.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;Condition of swelling;Imageological examination;Medication characteristics: dosage, course of treatment, combined medication;

Secondary

MeasureTime frame
Clinical signs: presence or absence of tenderness, percussion pain, and abnormal activity;Analysis of TCM syndromes/symptoms and signs;Bone mineral density examination room;General information: age, gender, occupation, admission condition, admission department, length of hospital stay, etc;Adverse reactions, such as dry mouth, dizziness, nausea, vomiting, diarrhea, etc;Liver and kidney function indexes;

Countries

China

Contacts

Public ContactWeiheng Chen

Beijing University Of Chinese Medicine Third Affiliated Hospital

drchenweiheng@163.com+86 135 1101 3261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026